EZH2 promotes the expression of LPA1 by mediating microRNA-139 promoter methylation to accelerate the development of ovarian cancer
Abstract Background It has been known that ovarian cancer (OC) is a leading cause for women mortality globally. We aimed to analyze the underlying mechanism supporting that enhancer of zeste homolog 2 (EZH2) affected the development of OC via the involvement of microRNA-139 (miR-139)/transforming gr...
Main Authors: | Dongbo Wu, Fanglan Wu, Birong Li, Wei Huang, Donglian Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-11-01
|
Series: | Cancer Cell International |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12935-020-01622-z |
Similar Items
-
Inactivation of Ezh2 Upregulates Gfi1 and Drives Aggressive Myc-Driven Group 3 Medulloblastoma
by: BaoHan T. Vo, et al.
Published: (2017-03-01) -
Long Intergenic Noncoding RNA 00511 Acts as an Oncogene in Non–small-cell Lung Cancer by Binding to EZH2 and Suppressing p57
by: Cheng-Cao Sun, et al.
Published: (2016-01-01) -
Enhancer of zeste acts as a major developmental regulator of Ciona intestinalis embryogenesis
by: Emilie Le Goff, et al.
Published: (2015-09-01) -
Long non-coding RNA TTN-AS1 promotes tumorigenesis of ovarian cancer through modulating the miR-139-5p/ROCK2 axis
by: Xiaoxia Liu, et al.
Published: (2020-05-01) -
Polycomb Repressor Complex 2 in Genomic Instability and Cancer
by: Zoe Veneti, et al.
Published: (2017-07-01)